The World Agri-Tech Investment Summit is Europe’s annual meeting place for the global agri-tech industry.
With a specific focus on the application of big data in agri-tech, and in-depth analysis of the market opportunity for biopesticides, seed treatment and drought-resilience, the 2014 summit will bring together global leaders in resource-efficient agriculture with the world’s most innovative technology developers and the international clean-tech investment community.
Highlights of the 2014 summit include:
What delegates had to say about the World Agri-Tech Investment Summit 2013:
“On the behalf of Valley Irrigation, we would like to thank World Agri-Tech Investment summit for bringing together Government representatives, NGOs, Agricultural input manufacturers and suppliers, Ag technology/service start-ups as well as investors in order to project the impact of technologies on the agricultural production value chain. The information presented as well as the exchange between panelists and attendants was rich and provided a good view of coming trends in the Ag space.” Francois Levesque, Director, International Dealer Development, Valley Irrigation
“I want to congratulate you on such a well-organised, informative and exciting event: it was a real pleasure to participate and as a fellow-organiser, I admired the sheer professionalism of the whole team and know how much it takes to make such an event run smoothly.” Anne Miller, Associate Director (Research), Environmental Sustainability Knowledge Transfer Network
“I thought the Summit was excellent. Well run, professional and attended by a very good cross-section of the industry…and not too big. From our perspective, I particularly enjoyed the AgTech showcase. I look forward to taking part again next year.” Michael Dean, AgFunder
“Congratulations on the first World Agri-Tech Investment Summit. This was a good event with a diverse mixture of investors, government policy makers and Agri-tech companies. And, the event attracted participants from around the globe. Definitely a worthwhile venture – one worth repeating!” Dave Smardon, Bioenterprise Capital